HMOX1 and diabetes mellitus: Previous studies have revealed that HO-1 exerts strong protective effects in preclinical models of several diseases, including cardiovascular and cerebrovascular disease, diabetes, sepsis, trauma, vascular proliferative diseases, acute lung injury, liver injury, gut ischemia/reperfusion injury, and tumors (47, 48).